<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03540680</url>
  </required_header>
  <id_info>
    <org_study_id>DBP16</org_study_id>
    <nct_id>NCT03540680</nct_id>
  </id_info>
  <brief_title>p16Ink4a in Bronchopulmonary Dysplasia in Children</brief_title>
  <acronym>DBP16</acronym>
  <official_title>Case-control Study Evaluating the Impact of p16Ink4a in Bronchopulmonary Dysplasia in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal Creteil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Intercommunal Creteil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The bronchopulmonary dysplasia (BPD) is a respiratory disease of the premature child which
      lead to a reduction of gas exchange surface and to a prolonged respiratory failure. This
      disease has morphologic and functional consequences at adulthood and is today considered to
      be an early determinant of respiratory diseases at adulthood.

      The physiopathology of BPD is not well known. Several mechanisms could be involved especially
      a reparation failure favored by an increase of cellular senescence which is a permanent stop
      of cellular proliferation. The transcription factor 16 Ink4a, considered as a marker of
      aging, is one of the essential markers of senescence. Its increase during prematurity was
      shown at the blood cells of the cordon, but its involvement in BPD and its evolution in child
      are not yet studied.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 7, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Actual">September 3, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>p16 expression</measure>
    <time_frame>Day 1</time_frame>
    <description>p16 expression measured by qPCR in newborns cord blood cells and in circulating leukocytes of children aged from 7 to 15</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Telomeres length</measure>
    <time_frame>Day 1</time_frame>
    <description>Telomeres length of circulating leukocytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genetic expression of p21, p53, H2Ax</measure>
    <time_frame>Day 1</time_frame>
    <description>Genetic expression of p21, p53, H2Ax of circulating leukocytes</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Bronchopulmonary Dysplasia</condition>
  <arm_group>
    <arm_group_label>Term newborns (≥37GA)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Blood punction on the cordon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Premature newborns</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Blood punction on the cordon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Child between 7 and 15 years old with BPD</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Blood punction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Child between 7 and 15 years old without BPD</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Blood punction</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood punction</intervention_name>
    <description>For the arms &quot;Term newborns (≥37GA)&quot; and &quot;Premature newborns&quot; the only intervention is a blood punction on the cordon.
For the arms &quot;Child between 7 and 15 years old&quot; with or without BPD the only intervention is a blood punction on peripheral blood.</description>
    <arm_group_label>Child between 7 and 15 years old with BPD</arm_group_label>
    <arm_group_label>Child between 7 and 15 years old without BPD</arm_group_label>
    <arm_group_label>Premature newborns</arm_group_label>
    <arm_group_label>Term newborns (≥37GA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Premature(&lt; 28 GA) neonates

          -  Alive neonate born at less than 28 gestational age

          -  Signed inform consent

        Term neonates:

          -  Alive neonate born at least at 37 GA or more

          -  Signed inform consent

        Child from 7 to 15 years old with BPD:

          -  Child from 7 to 15 years old

          -  Child with a BPD diagnosed

          -  Signed inform consent

        Child from 7 to 15 years old without BPD:

          -  Child from 7 to 15 years old

          -  Child receiving a blood test

          -  Signed inform consent

        Exclusion Criteria:

        Premature (&lt; 28 GA) and term neonates:

        -Congenital malformation

        Child from 7 to 15 years old with BPD:

          -  Cystic fibrosis

          -  Evolutive cancer

          -  Chronic inflammatory disease

          -  Known anemia

          -  Refusal of participation of child or parental authority

        Child from 7 to 15 years old without BPD:

          -  Other respiratory disease: severe asthma, cystic fibrosis, deficit AAT, bronchial
             dilatation

          -  Evolutive cancer

          -  Chronic inflammatory disease

          -  Known anemia

          -  Refusal of participation of child or parental authority
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ralph EPAUD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHI Créteil</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal de Créteil</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 17, 2018</study_first_submitted>
  <study_first_submitted_qc>May 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2018</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchopulmonary Dysplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

